Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, I
This new collaboration unites leaders in cystic fibrosis gene therapy, lenti...
2018-08-08
文传商讯
Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for
rAd-IFN/Syn3, a novel gene therapy, is in Phase 3 development to treat high-...
2018-05-10
文传商讯
Pradaxa (dabigatran etexilate) dual therapy showed lower rates of major
RE-DUAL PCI showed large reductions in the incidence of bleeding complicatio...
2017-08-29
文传商讯
New European study highlights differing priorities in physician’s ther
Data showed that 60% of physicians prioritised factors related to maintainin...
2016-11-10
文传商讯
